Thomas Kennedy's most recent trade in Textron Inc. was a trade of 10,300 Common Stock done at an average price of $96.0 . Disclosure was reported to the exchange on April 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Textron | Thomas Kennedy | Director | Purchase of securities on an exchange or from another person at price $ 95.98 per share. | 29 Apr 2026 | 10,300 | 20,162 (0%) | 0% | 96.0 | 988,594 | Common Stock |
| Textron | Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2026 | 2,061 | 9,862 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 3,507 | 8,661 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.25 per share. | 07 Aug 2025 | 1,959 | 6,702 (0%) | 0% | 111.3 | 217,940 | Ordinary Shares |
| Sun Country Airlines Holdings Inc | Thomas C. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 10,390 | 37,862 | - | 0 | Common Stock, par value $0.01 per share | |
| Textron | Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 2,794 | 7,801 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 3,731 | 5,154 (0%) | 0% | 0 | Ordinary Shares | |
| Sun Country Airlines Holdings Inc | Thomas C. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,386 | 27,472 | - | 0 | Common Stock, par value $0.01 per share | |
| Textron | Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 1,756 | 5,007 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,423 | 1,423 (0%) | 0% | 0 | Common Stock | |
| Sun Country Airlines Holdings Inc | Thomas C. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,186 | 16,086 | - | 0 | Common Stock, par value $0.01 per share | |
| Textron | Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 2,517 | 3,251 (0%) | 0% | 0 | Common Stock | |
| Textron | Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 734 | 734 (0%) | 0% | 0 | Common Stock | |
| Sun Country Airlines Holdings Inc | Thomas C. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,945 | 9,900 | - | 0 | Common stock, par value $0.01 per share | |
| Sun Country Airlines Holdings Inc | Thomas C. Kennedy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 2,955 | 2,955 | - | - | Common stock, par value $0.01 per share | |
| Sun Country Airlines Holdings Inc | Thomas C. Kennedy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 2,955 | 0 | - | - | Restricted Share Units |